YPYu. A. Pigareva

Yu. A. Pigareva

*This is an algorithmically generated author record based on publicly available information.

Yu. A. Pigareva has a total of 27 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • A case of non-alcoholic Wernicke’s encephalopathy in a young patient after bariatric surgery

    by O. S. Arisheva, Yu. A. Pigareva, O. P. Artyukov, I. V. Damulin, A. A. Strutsenko, L. A. Goreva, M. A. Markova, S. A. Lovchikova, R. G. Akzhigitov

    Wernicke’s encephalopathy is an acute neurological condition, the primary etiological factor of which is thiamine deficiency, most commonly associated with chronic alcohol intoxication. However, the occurrence of this condition due to other causes is frequently overlooked by clinicians, resulting in delayed diagnosis, severe cerebral and psychiatric complications, and death. The mechanisms leading to this complication are multifactorial and include inadequate nutritional intake (intractable vomiting, insufficient nutrition), increased metabolic demand (thyrotoxicosis, malignancy), and impaired absorption (surgical interventions on the gastrointestinal tract, including bariatric procedures). Within the spectrum of bariatric interventions, Wernicke’s encephalopathy is more frequently observed after malabsorptive procedures, which is attributable to the passage of food bypassing the primary sites of nutrient absorption. The difficulty in verifying the diagnosis lies in the similarity between the clinical manifestations of vitamin B1 deficiency and postoperative symptoms following bariatric surgery, limited awareness of this complication among specialists, and the lack of technical diagnostic capabilities. This article presents a clinical case of a young female patient with Wernicke encephalopathy that developed after gastric bypass surgery.

  • Omega-3 fatty acids: bioavailability characteristics

    by E. V. Prokopenko, S. V. Orlova, E. A. Nikitina, N. V. Balashova, Yu. A. Pigareva

    Long-chain polyunsaturated fatty acids (PUFAs) of the omega-3 class, primarily eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), have remained at the forefront of basic medicine, nutritional science, and clinical pharmacology for many decades. Large-scale epidemiological data consistently demonstrate that high consumption of marine lipids is associated with a reduced risk of cardiovascular, neurodegenerative, and systemic metabolic diseases. However, when these epidemiological observations are translated into the setting of randomized clinical trials investigating standardized omega-3 supplements and prescription formulations, the scientific community is regularly confronted with heterogeneous and, at times, directly contradictory results. Such inconsistency in clinical outcomes is driven not only by differences in study design, dosage regimens, or the severity of patients’ underlying pathology, but also by fundamental biochemical factors that are often underestimated in routine clinical practice. Of key importance are the source of the raw material, the chemical and stereochemical forms of lipid molecules, and the presence of accompanying active compounds (antioxidants and structural lipids), which together determine molecular stability, digestion kinetics, bioavailability, and the ability of active metabolites to reach target cells.

  • Open Access

    Improving the effectiveness of medical rehabilitation of patients with ischemic heart disease using dihydroquercetin

    by S. V. Orlova, E. A. Nikitina, N. V. Balashova, S. F. Ivanov, С. Л. Вольпе, V. V. Tatarinov, Yu. A. Pigareva, I. Yu. Drachev

    Cardiovascular diseases (CVD) are a leading cause of death in all industrialized countries. Coronary heart disease (CHD) occupies a leading position among CVDs. The relevance of CHD is determined by its role in disability and mortality in the population, as well as the financial costs associated with the treatment and rehabilitation of patients. The goals of treating patients with CHD are to improve quality of life by reducing the frequency of angina attacks and preventing acute myocardial infarction. In addition to lipid metabolism disorders, hemostatic disorders play a significant role in the development and progression of CHD. In particular, increased platelet activity leads to changes in blood rheology and an increased tendency to thrombosis, which leads to impaired microcirculation. Therefore, the inclusion of agents that target pathogenic mechanisms in rehabilitation programs for such patients appears promising. One such agent is the bioflavonoid dihydroquercetin (DHA), obtained from Siberian larch wood. It stimulates tissue blood flow, stabilizes microvascular barrier function, reduces capillary wall permeability, improves blood rheology, and thereby helps reduce microvascular congestion. The aim of this study was to evaluate the effectiveness of the dietary supplement «Dihydroquercetin» (Evalar, JSC) in the comprehensive treatment of patients with coronary heart disease. The study demonstrated the positive effects of dihydroquercetin on cardiovascular disease (CVD): significant improvement in peripheral microcirculation hemodynamic parameters, a tendency toward normalization of cerebral hemodynamics, and a positive effect on lipid metabolism. This opens up new possibilities for the use of plant-based antioxidants in practical medicine.

  • Open Access

    Nutritional correction of non-alcoholic fatty liver disease with the inclusion of a dietary supplement containing omega-3 PUFAs

    by S. V. Orlova, E. V. Prokopenko, E. A. Nikitina, N. V. Balashova, Yu. A. Pigareva, O. I. Tarasova, I. S. Minosyan, I. Yu. Drachev

    Non-alcoholic fatty liver disease (NAFLD) is one of the most prevalent chronic liver pathologies worldwide, affecting more than a quarter of the global population. The disease is closely associated with obesity, insulin resistance, and metabolic syndrome. Although the Mediterranean diet has proven effective, adherence to it remains challenging, driving interest in combination therapy that includes dietary supplements. Omega-3 polyunsaturated fatty acids (EPA and DHA) are of particular importance, with a deficiency rate of 68.5 % in the Russian Federation and even lower levels observed in NAFLD patients. Objective. To evaluate the efficacy of the dietary supplement «Triple Omega-3 950 mg» (ZAO “Evalar”) as part of nutritional correction in patients with NAFLD at the steatosis stage. Materials and methods. An open-label comparative 6-month study enrolled 74 patients with NAFLD. The main group (n=50) received dietary therapy plus the supplement «Triple Omega-3 950 mg» (ZAO “Evalar”) (1 capsule/day: 950 mg omega-3 PUFAs, including not less than 550 mg EPA and not less than 230 mg DHA). The comparison group (n=24) received dietary therapy alone. Biochemical blood parameters, lipid profile, HOMA-IR index, liver enzymes, and abdominal ultrasound were assessed. Results. The main group demonstrated a significant reduction in triglycerides (from 1.29±0.06 to 1.08±0.08 mmol/L) and LDL cholesterol (from 116.3±5.04 to 103.96±3.3 mg/mL) compared to the comparison group (pConclusion. The inclusion of the dietary supplement «Triple Omega-3 950 mg» (ZAO “Evalar”) in comprehensive dietary therapy for patients with NAFLD at the steatosis stage significantly improves lipid profile, reduces insulin resistance, alleviates cytolysis and cholestasis, and enhances patients’ quality of life. This product can be recommended as adjunctive therapy for NAFLD in combination with diet and physical activity.

  • Glycemia under control: the role of micro- and phytonutrients

    by E. A. Nikitina, S. V. Orlova, T. T. Batysheva, N. V. Balashova, M. V. Alekseeva, Yu. A. Pigareva

    Type 2 diabetes mellitus (T2DM) is a global epidemic driven by unbalanced nutrition and physical inactivity. Body weight reduction by 5% and more improves insulin sensitivity, normalizes glycemia and reduces complication risks. However, patients with T2DM frequently demonstrate deficiencies in key vitamins (C, B-complex) and minerals (magnesium, zinc, chromium), which may exacerbate metabolic disorders and increase risk of complications. Addressing these micronutrient deficiencies through dietary fiber (inulin) and phytochemicals (Gymnema sylvestre) supplementation helps improve carbohydrate and lipid metabolism. Optimal nutritional therapy should combine balanced diet, physical activity and personalized micronutrient support including multivitamin-multimineral complexes and phytonutrients.

  • Vitamin D: What do we know by 2024? A review of the evidence on the effects of vitamin D supplementation on the human body

    by S. V. Orlova, E. A. Nikitina, A. N. Vodolazkaya, T. T. Batysheva, M. V. Alekseeva, N. V. Balashova, Yu. A. Pigareva, E. V. Prokopenko

    Vitamin D plays an import role in the regulation of calcium-phosphorus metabolism, metabolic processes and the cell cycle.Over the years, the mechanisms of molecular action of vitamin D in various cells, organs and tissues have been well studied. The widespread prevalence of vitamin D deficiency, established on the basis of laboratory diagnostics, has led to the development and implementation of programs for the correction of hypovitaminosis D. However, the question of the clinical effectiveness of these programs remains open. In this article, we review studies and meta-analyses of data that have assessed the preventive and therapeutic efficacy and safety of physiological and high doses of vitamin D.


  • The role of individual neuronutrients in optimizing nutritional therapy for neurological patients

    by S. V. Orlova, E. A. Nikitina, N. V. Balashova, S. G. Gribakin, E. V. Prokopenko, A. N. Vodolazkaya, Yu. A. Pigareva

    Neurodietology is a multidisciplinary science based on knowledge of neuroscience and dietology and aiming to optimize the treatment of neuropsychiatric diseases through qualitative and quantitative modulation of the composition of diets, alimentary prevention of diseases of the nervous system, when the latter is possible, as well as optimization of psychomotor and intellectual functions. It should be noted that neurodietology and approaches to the choice of therapeutic nutrition every year occupy an increasingly strong position in world clinical medicine. The variability of nutritional approaches to the practical treatment of neurological pathology in patients reflects the versatility of modern neurodietology. Therefore, it is no coincidence that childhood neurodietology has been widely used in Russia, which cannot be said about nutritional approaches in the treatment of adult patients of this profile. In addition, violations of the nutritional status and the lack of its timely correction reduce the effectiveness of rehabilitation measures – the most important link in the complex treatment of neurological patients, prevention of disability and increasing social adaptation. If it is impossible to provide an adequate level of intake of nutrients and energy in the standard way, it is necessary to prescribe nutritional support in a timely manner using specialized food products, including biologically active food supplements.


  • Open Access

    The role of omega PUFAs in the complex prevention and treatment of certain skin diseases

    by E. V. Prokopenko, S. V. Orlova, E. A. Nikitina, A. N. Vodolazkaya, N. V. Balashova, Yu. A. Pigareva

    A growing body of nutritional evidence shows that we are indeed «what we eat» and the fatty acid content of our diet has far-reaching physiological implications, many of which we are only just beginning to understand. A variety of fatty acids are present in the human diet, in the human bloodstream, and in human cells and tissues. Fatty acids are energy sources and components of membranes. They have biological activities that affect cellular and tissue metabolism, function and response, hormonal and other signals. Through these effects, fatty acids affect health, well-being, and disease risk. While the health effects of fatty acids have traditionally been of greatest interest in cardiovascular disease, metabolic diseases such as diabetes, inflammatory diseases, and reproductive and neurocognitive disorders, it is now clear that fatty acids are also involved in a number of other diseases, including skin diseases, atopic dermatitis, psoriasis, rosacea, acne.


  • Open Access

    The problem of magnesium deficiency and metabolic syndrome

    by E. A. Nikitina, S. V. Orlova, N. V. Balashova, Yu. A. Pigareva

    The epidemic of obesity, insulin resistance and diabetes mellitus currently observed in developed countries requires new approaches to the prevention and treatment. Besides the hypercaloric diet micronutrient deficiency is involved in the development of metabolic disorders. Recent diet changes due to the agrarian and food technological revolutions has led to the emergence of new micronutrient deficiencies, primarily magnesium. While its hypotonic action is well studied, magnesium’s positive effects on metabolism, anti-inflammatory and antioxidant effects are currently the focus of researchers’ attention. The magnesium preparations reduce insulin resistance, improves anthropometric and laboratory markers of the metabolic syndrome. Detection of magnesium deficiency, including subclinical one, and correction of magnesium status are important tasks for the prevention and complex therapy of the metabolic syndrome. Given the higher bioavailability and lower incidence of side effects, organic magnesium salts are preferable.

  • Open Access

    Vitamins and Minerals in Pregnancy Nutrition: Objections Management

    by S. V. Orlova, E. A. Nikitina, N. V. Balashova, S. G. Gribakin, Yu. A. Pigareva

    Optimal nutrition, balanced in calories and containing all essential nutrients in adequate amounts, is an important condition for the proper fetus development and pregnancy complications prevention. Vitamins and minerals play an essential role in the regulation of metabolism, cell proliferation and differentiation, growth and development of the fetus. They also affect the mother’s body, preventing the development of pregnancy-related diseases. Despite the obvious need for vitamins and minerals for the health of the pregnant woman and the fetus, questions remain about the advisability of additional intake of certain micronutrients and their dosages during pregnancy. Our article is devoted to the analysis of recent data on the intake of vitamins A, D, folic acid, iron, calcium and magnesium during pregnancy and their effect on the fetus and mother.